Presented at Precision Medicine Congress on September 15, 2015, this presentation describes Q² Solutions Comprehensive Cancer Panel content, how it was selected and design considerations – as well as performance characteristics and the impact of bioinformatic enhancement. This presentation will also highlight considerations in using the panel for genomic profiling of cancer patients. 

Download the presentation to learn more.

Speakers:
Thomas Halsey, Ph.D.,Associate Director, Genomic Research and Development
Victor Weigman, Ph.D. Associate Director, Translational Genomics